#Veeva Systems #Denmark #Copenhagen #Veeva Falcon #Vault AI

Veeva Summit: Paving the Way for AI in Biopharma

On May 28-29, Copenhagen played host to the Veeva R&D and Quality Summit Europe, an event that brought together over 2,000 leaders from the life sciences sector. This year’s summit highlighted critical advancements in artificial intelligence (AI) and its transformative role in biopharma. Veeva Systems, a leader in cloud-based solutions for the life sciences, showcased its upcoming innovative platforms, Veeva Falcon and Vault AI, setting the stage for a new era in drug development and operational efficiency.

Key Innovations Unveiled

Veeva Falcon

One of the major highlights was the unveiling of Veeva Falcon, a groundbreaking automated work platform designed to optimize document handling and quality control processes within clinical trials. Falcon aims to revolutionize how complex regulatory requirements are managed, promising to enhance compliance while reducing costs and development timelines. Set to launch for early users at the end of 2026, Falcon will first focus on improving efficiency in clinical trial master file document handling and regulatory communications.

Vault AI

In conjunction with Falcon, Veeva introduced Vault AI, an array of intelligent agents designed to streamline workflows across its suite of applications. Initially available starting from the summit, Vault AI is set to expand its functionalities across all Veeva applications by August 2026. This enhancement is a significant leap toward integrating AI capabilities into everyday operations, thereby fostering a more agile and responsive workforce.

Industry Insights and Collaborations

The summit featured over 100 sessions, with insights shared by prominent figures from industry stalwarts such as AOP Health, Boehringer Ingelheim, GSK, and Novo Nordisk. These leaders presented strategies for enhancing connectivity and operational integration, emphasizing the importance of unified data systems to accelerate drug development. AOP Health discussed their initiative to link R&D, quality, and marketing through the Veeva Industry Cloud, exemplifying how connected systems can drive efficiency and responsiveness in the competitive biopharma landscape.

Enhancing Clinical Collaboration

Boehringer Ingelheim presented their comprehensive clinical operations model, which connects clinical sites and patients through unified data platforms. Similarly, GSK and Novo Nordisk highlighted their strategies for standardizing interactions with clinical sites to expedite activation times and improve performance metrics. These collaborations underscore a growing trend towards making clinical operations more efficient and data-driven.

Modernizing Quality and Compliance

Another focal point of the discussions was the modernization of quality and compliance processes facilitated by AI. Companies like Haleon and Sanofi are preparing to apply AI technologies to boost efficiency within quality management. Moreover, Novo Nordisk shared its approach to simplifying pharmacovigilance, showcasing their commitment to optimizing global data management. These advancements point towards a future where quality assurance processes are not only standardized but also significantly more efficient.

Impact Beyond the Summit

As Rik van Mol, Senior Vice President of Veeva Development Cloud, put it, “The ideas shared and the connections made at the Veeva Summit will have a far-reaching impact, driving the industry towards an AI-powered future.” The innovations presented during this conference herald a transformation in how biopharmaceutical companies will operate, encouraging industry-wide collaboration and integration of technology.

Conclusion

The Veeva R&D and Quality Summit served as a critical forum for discussing the future of AI in biopharma. With innovative tools like Veeva Falcon and Vault AI on the horizon, the potential to enhance operational efficacy and streamline processes is vast. For those seeking to stay at the forefront of life sciences innovation, the insights drawn from this summit provide a roadmap for navigating the evolving landscape of biopharmaceutical development.

For further information on Veeva’s new technologies and session recordings, visit Veeva Connect.